Annual FCF
-$73.50 M
+$50.97 M+40.95%
December 31, 2024
Summary
- As of March 12, 2025, ITCI annual free cash flow is -$73.50 million, with the most recent change of +$50.97 million (+40.95%) on December 31, 2024.
- During the last 3 years, ITCI annual FCF has risen by +$186.37 million (+71.72%).
- ITCI annual FCF is now -288.02% below its all-time high of -$18.94 million, reached on December 31, 2012.
Performance
ITCI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$12.65 M
+$14.57 M+53.52%
December 1, 2024
Summary
- As of March 12, 2025, ITCI quarterly free cash flow is -$12.65 million, with the most recent change of +$14.57 million (+53.52%) on December 1, 2024.
- Over the past year, ITCI quarterly FCF has stayed the same.
- ITCI quarterly FCF is now -2687.12% below its all-time high of $489.00 thousand, reached on June 30, 2024.
Performance
ITCI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$73.50 M
-$10.59 M-16.83%
December 1, 2024
Summary
- As of March 12, 2025, ITCI TTM free cash flow is -$73.50 million, with the most recent change of -$10.59 million (-16.83%) on December 1, 2024.
- Over the past year, ITCI TTM FCF has stayed the same.
- ITCI TTM FCF is now -742314.14% below its all-time high of -$9900.00, reached on June 30, 2013.
Performance
ITCI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ITCI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.0% | 0.0% | 0.0% |
| 3 y3 years | +71.7% | +50.5% | +54.5% |
| 5 y5 years | +42.9% | +50.5% | +54.5% |
ITCI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.9% | -2687.1% | +86.7% | -20.0% | +77.8% |
| 5 y | 5-year | at high | +72.9% | -2687.1% | +86.7% | -20.0% | +77.8% |
| alltime | all time | -288.0% | +72.9% | -2687.1% | +86.7% | <-9999.0% | +77.8% |
Intra-Cellular Therapies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$73.50 M(-40.9%) | - | - |
| Dec 2024 | - | -$12.65 M(-53.5%) | -$73.50 M(+16.8%) |
| Sep 2024 | - | -$27.22 M(-5666.7%) | -$62.91 M(+2.7%) |
| Jun 2024 | - | $489.00 K(-101.4%) | -$61.23 M(-37.9%) |
| Mar 2024 | - | -$34.12 M(+1554.5%) | -$98.52 M(-20.8%) |
| Dec 2023 | -$124.47 M(-54.1%) | -$2.06 M(-91.9%) | -$124.47 M(-23.0%) |
| Sep 2023 | - | -$25.54 M(-30.6%) | -$161.57 M(-14.7%) |
| Jun 2023 | - | -$36.80 M(-38.7%) | -$189.50 M(-23.5%) |
| Mar 2023 | - | -$60.07 M(+53.4%) | -$247.62 M(-8.6%) |
| Dec 2022 | -$270.96 M(+4.3%) | -$39.16 M(-26.8%) | -$270.96 M(-11.2%) |
| Sep 2022 | - | -$53.47 M(-43.7%) | -$304.98 M(-7.9%) |
| Jun 2022 | - | -$94.92 M(+13.8%) | -$331.09 M(+12.0%) |
| Mar 2022 | - | -$83.42 M(+14.0%) | -$295.52 M(+13.7%) |
| Dec 2021 | -$259.87 M(+12.8%) | -$73.19 M(-8.0%) | -$259.87 M(+1.9%) |
| Sep 2021 | - | -$79.58 M(+34.1%) | -$255.00 M(+6.6%) |
| Jun 2021 | - | -$59.34 M(+24.2%) | -$239.17 M(+5.4%) |
| Mar 2021 | - | -$47.77 M(-30.1%) | -$226.86 M(-1.5%) |
| Dec 2020 | -$230.34 M(+79.0%) | -$68.32 M(+7.2%) | -$230.34 M(+17.3%) |
| Sep 2020 | - | -$63.75 M(+35.6%) | -$196.43 M(+20.6%) |
| Jun 2020 | - | -$47.02 M(-8.2%) | -$162.89 M(+12.9%) |
| Mar 2020 | - | -$51.25 M(+49.0%) | -$144.24 M(+12.1%) |
| Dec 2019 | -$128.68 M | -$34.41 M(+13.9%) | -$128.68 M(+4.2%) |
| Sep 2019 | - | -$30.21 M(+6.5%) | -$123.50 M(+1.5%) |
| Jun 2019 | - | -$28.37 M(-20.5%) | -$121.71 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$35.70 M(+22.2%) | -$126.98 M(+7.1%) |
| Dec 2018 | -$118.56 M(+46.0%) | -$29.22 M(+2.8%) | -$118.56 M(+3.4%) |
| Sep 2018 | - | -$28.43 M(-15.5%) | -$114.65 M(+13.8%) |
| Jun 2018 | - | -$33.64 M(+23.3%) | -$100.74 M(+9.4%) |
| Mar 2018 | - | -$27.28 M(+7.8%) | -$92.07 M(+13.4%) |
| Dec 2017 | -$81.22 M(-11.1%) | -$25.31 M(+74.3%) | -$81.22 M(-3.7%) |
| Sep 2017 | - | -$14.52 M(-41.8%) | -$84.36 M(-15.2%) |
| Jun 2017 | - | -$24.96 M(+52.0%) | -$99.51 M(+13.0%) |
| Mar 2017 | - | -$16.43 M(-42.3%) | -$88.08 M(-3.5%) |
| Dec 2016 | -$91.31 M(-11.5%) | -$28.45 M(-4.1%) | -$91.31 M(-6.8%) |
| Sep 2016 | - | -$29.67 M(+119.2%) | -$97.95 M(+10.2%) |
| Jun 2016 | - | -$13.54 M(-31.1%) | -$88.90 M(-16.6%) |
| Mar 2016 | - | -$19.65 M(-44.0%) | -$106.57 M(+3.3%) |
| Dec 2015 | -$103.14 M(+352.0%) | -$35.09 M(+70.2%) | -$103.14 M(+38.9%) |
| Sep 2015 | - | -$20.62 M(-33.9%) | -$74.26 M(+27.9%) |
| Jun 2015 | - | -$31.20 M(+92.2%) | -$58.06 M(+81.1%) |
| Mar 2015 | - | -$16.23 M(+161.4%) | -$32.06 M(+40.5%) |
| Dec 2014 | -$22.82 M(+0.9%) | -$6.21 M(+40.5%) | -$22.82 M(+37.4%) |
| Sep 2014 | - | -$4.42 M(-15.0%) | -$16.61 M(+36.3%) |
| Jun 2014 | - | -$5.20 M(-25.5%) | -$12.19 M(+74.2%) |
| Mar 2014 | - | -$6.99 M(>+9900.0%) | -$7.00 M(>+9900.0%) |
| Dec 2013 | -$22.62 M(+19.4%) | - | - |
| Jun 2013 | - | -$9900.00 | -$9900.00 |
| Dec 2012 | -$18.94 M | - | - |
FAQ
- What is Intra-Cellular Therapies annual free cash flow?
- What is the all time high annual FCF for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual FCF year-on-year change?
- What is Intra-Cellular Therapies quarterly free cash flow?
- What is the all time high quarterly FCF for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly FCF year-on-year change?
- What is Intra-Cellular Therapies TTM free cash flow?
- What is the all time high TTM FCF for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM FCF year-on-year change?
What is Intra-Cellular Therapies annual free cash flow?
The current annual FCF of ITCI is -$73.50 M
What is the all time high annual FCF for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual free cash flow is -$18.94 M
What is Intra-Cellular Therapies annual FCF year-on-year change?
Over the past year, ITCI annual free cash flow has changed by +$50.97 M (+40.95%)
What is Intra-Cellular Therapies quarterly free cash flow?
The current quarterly FCF of ITCI is -$12.65 M
What is the all time high quarterly FCF for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly free cash flow is $489.00 K
What is Intra-Cellular Therapies quarterly FCF year-on-year change?
Over the past year, ITCI quarterly free cash flow has changed by $0.00 (0.00%)
What is Intra-Cellular Therapies TTM free cash flow?
The current TTM FCF of ITCI is -$73.50 M
What is the all time high TTM FCF for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM free cash flow is -$9900.00
What is Intra-Cellular Therapies TTM FCF year-on-year change?
Over the past year, ITCI TTM free cash flow has changed by $0.00 (0.00%)